BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:26 PM
 | 
Mar 29, 2010
 |  BC Extra  |  Clinical News

Antisoma falls on ASA404 Phase III halt

Antisoma plc (LSE:ASM) fell 24p (75%) to 8p on Monday after partner Novartis AG (NYSE:NVS; SIX:NOVN) stopped the Phase III ATTRACT-1 trial of ASA404 in non-small cell lung cancer (NSCLC). Antisoma said an interim analysis...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >